Global Spinal Cord Injury Pipeline Review, H1 2016 - Analysis, Technologies & Forecasts - Key Vendors: Athersys, Lpath, Tumorend - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Spinal Cord Injury - Pipeline Review, H1 2016" report to their offering.

The report provides comprehensive information on the therapeutics under development for Spinal Cord Injury, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Spinal Cord Injury and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision-making capabilities and helps to create effective counter-strategies to gain competitive advantage.

Scope:

  • The report provides a snapshot of the global therapeutic landscape of Spinal Cord Injury
  • The report reviews pipeline therapeutics for Spinal Cord Injury by companies and universities/research institutes based on information derived from company and industry-specific sources
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report features descriptive drug profiles for the pipeline products, which include product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in Spinal Cord Injury therapeutics and lists all their major and minor projects
  • The report assesses Spinal Cord Injury therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report reviews the latest news related to pipeline therapeutics for Spinal Cord Injury

Companies Mentioned Include:

  • Acorda Therapeutics, Inc.
  • Asterias Biotherapeutics, Inc.
  • Asubio Pharma Co., Ltd.
  • Athersys, Inc.
  • BioArctic Neuroscience AB
  • Lipopharma Therapeutics SL
  • Lpath, Inc.
  • MandalMed, Inc.
  • Mapreg S.A.S.
  • Pharmicell Co., Ltd.
  • Protagenic Therapeutics Inc.
  • Sirnaomics, Inc.
  • StemCells, Inc.
  • Stemedica Cell Technologies, Inc.
  • TissueGene, Inc.
  • Tumorend, LLC
  • Vertex Pharmaceuticals Incorporated
  • Vicore Pharma AB

For more information visit http://www.researchandmarkets.com/research/pdzw4d/spinal_cord.

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For EST Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For EST Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716